
OCRA Supports The CLINICAL TREATMENT Act (H.R. 913)
For many ovarian cancer patients, clinical trials offer a promising avenue for expanding treatment options and extending survival. Unfortunately, participation comes at a steep financial cost that is often prohibitive … Continued